SAGE logo

Sage Therapeutics (SAGE) CAPEX

annual CAPEX:

N/A
December 31, 2024

Summary

  • SAGE annual capital expenditures is not available.

Performance

1-year change

-

3-year change

-

5-year change

-

15-year change

-

SAGE CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

$5.75M
SAGE annual capital expenditures is currently at an all-time high

3-year low

$372.00K
SAGE annual capital expenditures is currently at its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
SAGE previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
SAGE next annual earnings announcement has not yet been scheduled

OtherSAGEcash flow metrics

annual FCF

-$267.19M
SAGE annual free cash flow is -$267.19 million

annual CFO

-$267.19M
SAGE annual cash flow from operations is -$267.19 million

annual CFI

$266.68M
SAGE annual cash flow from investing activities is $266.68 million

annual CFF

$10.66M
SAGE annual cash flow from financing activities is $10.66 million

quarterly CAPEX:

N/A
March 31, 2025

Summary

  • SAGE quarterly capital expenditures is not available.

Performance

3-month change

-

1-year change

-

3-year change

-

5-year change

-

SAGE quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

$2.18M
SAGE quarterly capital expenditures is currently at an all-time high

3-year low

-$112.00K
SAGE quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
SAGE previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Jul 31, 2025
SAGE next earnings announcement is scheduled for Jul 31, 2025

OtherSAGEcash flow metrics

quarterly FCF

-$81.73M
SAGE quarterly free cash flow is -$81.73 million

quarterly CFO

-$81.73M
SAGE quarterly cash flow from operations is -$81.73 million

quarterly CFI

$45.78M
SAGE quarterly cash flow from investing activities is $45.78 million

quarterly CFF

$148.00K
SAGE quarterly cash flow from financing activities is $148.00 thousand

TTM CAPEX:

N/A
March 31, 2025

Summary

  • SAGE TTM capital expenditures is not available.

Performance

3-month change

-

1-year change

-

3-year change

-

5-year change

-

SAGE TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-time high

$6.19M
SAGE TTM capital expenditures is currently at an all-time high

3-year low

$291.00K
SAGE TTM capital expenditures is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
SAGE previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Jul 31, 2025
SAGE next earnings announcement is scheduled for Jul 31, 2025

OtherSAGEcash flow metrics

TTM FCF

-$311.09M
SAGE TTM free cash flow is -$311.09 million

TTM CFO

-$311.09M
SAGE TTM cash flow from operations is -$311.09 million

TTM CFI

$173.03M
SAGE TTM cash flow from investing activities is $173.03 million

TTM CFF

$9.25M
SAGE TTM cash flow from financing activities is $9.25 million

SAGE CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

SAGE CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

SAGE CAPEX History

DateAnnualQuarterlyTTM
Dec 2023
$553.00K(-41.0%)
-$112.00K(-134.1%)
$553.00K(-41.6%)
Sep 2023
-
$328.00K(+192.9%)
$947.00K(-3.7%)
Jun 2023
-
$112.00K(-50.2%)
$983.00K(-1.0%)
Mar 2023
-
$225.00K(-20.2%)
$993.00K(+6.0%)
Dec 2022
$937.00K(+151.9%)
$282.00K(-22.5%)
$937.00K(+43.1%)
Sep 2022
-
$364.00K(+198.4%)
$655.00K(+125.1%)
Jun 2022
-
$122.00K(-27.8%)
$291.00K(+72.2%)
Mar 2022
-
$169.00K(>+9900.0%)
$169.00K(-51.0%)
Dec 2021
$372.00K(+7.8%)
-
-
Dec 2020
$345.00K
$0.00(-100.0%)
$345.00K(-51.9%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$1000.00(-101.4%)
$718.00K(-73.0%)
Jun 2020
-
$70.00K(-74.6%)
$2.66M(-44.3%)
Mar 2020
-
$276.00K(-26.0%)
$4.77M(-17.1%)
Dec 2019
$5.75M(+101.1%)
$373.00K(-80.8%)
$5.75M(-7.0%)
Sep 2019
-
$1.94M(-11.0%)
$6.19M(+18.0%)
Jun 2019
-
$2.18M(+73.5%)
$5.24M(+51.3%)
Mar 2019
-
$1.26M(+55.6%)
$3.46M(+56.9%)
Dec 2018
$2.86M
$808.00K(-19.0%)
$2.21M(+57.7%)
Sep 2018
-
$998.00K(+148.3%)
$1.40M(+248.3%)
Jun 2018
-
$402.00K
$402.00K

FAQ

  • What is the all time high annual CAPEX for Sage Therapeutics?
  • What is the all time high quarterly CAPEX for Sage Therapeutics?
  • What is the all time high TTM CAPEX for Sage Therapeutics?

What is the all time high annual CAPEX for Sage Therapeutics?

Sage Therapeutics all-time high annual capital expenditures is $5.75M

What is the all time high quarterly CAPEX for Sage Therapeutics?

Sage Therapeutics all-time high quarterly capital expenditures is $2.18M

What is the all time high TTM CAPEX for Sage Therapeutics?

Sage Therapeutics all-time high TTM capital expenditures is $6.19M
On this page